HOLLY STRAIN: Open Payments
NPI 1104555010 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$345 in 15 payments from 8 companies in 2025. Trend: 2023 $240 · 2024 $882 · 2025 $345
Food & beverage: $345
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $114 |
| AKEBIA THERAPEUTICS INC | 2 | $61 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Lilly USA, LLC | 1 | $30 |
| Apellis Pharmaceuticals, Inc. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
Products named: Fabhalta, Vafseo, LOKELMA, JARDIANCE, Empaveli, JYNARQUE, BENLYSTA, Kerendia.
Industry payments across CO — which companies pay providers there.
